Journal
NANOMATERIALS
Volume 12, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/nano12050758
Keywords
curcumin; human serum albumin; Parkinson's disease; nanoparticle; dopaminergic neuron
Ask authors/readers for more resources
This study fabricated curcumin nanoparticles using human serum albumin as a carrier and found that these nanoparticles could ameliorate Parkinson's disease features in a C. elegans model.
Parkinson's disease is one of the most common degenerative disorders and is characterized by observable motor dysfunction and the loss of dopaminergic neurons. In this study, we fabricated curcumin nanoparticles using human serum albumin as a nanocarrier. Encapsulating curcumin is beneficial to improving its aqueous solubility and bioavailability. The curcumin-loaded HSA nanoparticles were acquired in the particle size and at the zeta potential of 200 nm and -10 mV, respectively. The curcumin-loaded human serum albumin nanoparticles ameliorated Parkinson's disease features in the C. elegans model, including body movement, basal slowing response, and the degeneration of dopaminergic neurons. These results suggest that curcumin nanoparticles have potential as a medicinal nanomaterial for preventing the progression of Parkinson's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available